Print this page
-
Targeted Genomic Analysis of Human Cancers.
Protocol: 001209Principal Investigator:
- Shridar Ganesan
Applicable Disease Sites: Any Site -
Targeted Genomic Analysis of Human Cancers.
Protocol: 001209Principal Investigator:
- Shridar Ganesan
Applicable Disease Sites: Any Site -
A youth-led intervention to reduce healthcare disparities in cancer screening
Protocol: 002531Applicable Disease Sites:
-
Faculty Perspectives on Pediatric Hematology Oncology Fourth Year Fellowships
Protocol: 002543Principal Investigator:
- Scott A Moerdler
Applicable Disease Sites: -
A survey of pediatric and adolescent and young adult (AYA) cancer patients primary care providers (PCPs) regarding communication with the oncology team
Protocol: 002549Principal Investigator:
- Dawn Tortajada
Applicable Disease Sites: Any Site -
A youth-led intervention to reduce healthcare disparities in cancer screening
Protocol: 002531Applicable Disease Sites:
-
Faculty Perspectives on Pediatric Hematology Oncology Fourth Year Fellowships
Protocol: 002543Principal Investigator:
- Scott A Moerdler
Applicable Disease Sites: -
A survey of pediatric and adolescent and young adult (AYA) cancer patients primary care providers (PCPs) regarding communication with the oncology team
Protocol: 002549Principal Investigator:
- Dawn Tortajada
Applicable Disease Sites: Any Site -
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies.
Protocol: 072014Applicable Disease Sites: Any Site
-
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies.
Protocol: 072014Applicable Disease Sites: Any Site
-
Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients with Suspected Regional Disease.
Protocol: 082410Principal Investigator:
- Thomas Jang
Applicable Disease Sites: Other Urinary -
Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients with Suspected Regional Disease.
Protocol: 082410Principal Investigator:
- Thomas Jang
Applicable Disease Sites: Other Urinary -
Project Every Child: A Registry, Eligibility Screening, Biology and Outcome Study.
Protocol: 111509Principal Investigator:
- Richard A Drachtman
Applicable Disease Sites: Any Site -
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors.
Protocol: 111702Principal Investigator:
- Nehal Parikh
Applicable Disease Sites: Any Site
Ovary
Prostate -
A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL).
Protocol: 111707Principal Investigator:
- Archana Sharma
Applicable Disease Sites: Lymphoid Leukemia -
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL).
Protocol: 111803Principal Investigator:
- Nehal Parikh
Applicable Disease Sites: Any Site